| 000 | 02731 a2200769 4500 | ||
|---|---|---|---|
| 005 | 20250514231508.0 | ||
| 264 | 0 | _c20050906 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a1535-6108 | ||
| 024 | 7 |
_a10.1016/j.ccr.2005.05.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSamuels, Yardena | |
| 245 | 0 | 0 |
_aMutant PIK3CA promotes cell growth and invasion of human cancer cells. _h[electronic resource] |
| 260 |
_bCancer cell _cJun 2005 |
||
| 300 |
_a561-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 | _aApoptosis Regulatory Proteins |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xgenetics |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aChromones _xpharmacology |
| 650 | 0 | 4 | _aClass I Phosphatidylinositol 3-Kinases |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aForkhead Box Protein O1 |
| 650 | 0 | 4 | _aForkhead Box Protein O3 |
| 650 | 0 | 4 | _aForkhead Transcription Factors |
| 650 | 0 | 4 | _aGene Targeting |
| 650 | 0 | 4 |
_aGrowth Substances _xdeficiency |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xdeficiency |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xphysiology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aMorpholines _xpharmacology |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _xgenetics |
| 650 | 0 | 4 |
_aNeoplasms, Experimental _xgenetics |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xgenetics |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-akt |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTNF-Related Apoptosis-Inducing Ligand |
| 650 | 0 | 4 |
_aTranscription Factors _xgenetics |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xphysiology |
| 650 | 0 | 4 |
_aXenograft Model Antitumor Assays _xmethods |
| 700 | 1 | _aDiaz, Luis A | |
| 700 | 1 | _aSchmidt-Kittler, Oleg | |
| 700 | 1 | _aCummins, Jordan M | |
| 700 | 1 | _aDelong, Laura | |
| 700 | 1 | _aCheong, Ian | |
| 700 | 1 | _aRago, Carlo | |
| 700 | 1 | _aHuso, David L | |
| 700 | 1 | _aLengauer, Christoph | |
| 700 | 1 | _aKinzler, Kenneth W | |
| 700 | 1 | _aVogelstein, Bert | |
| 700 | 1 | _aVelculescu, Victor E | |
| 773 | 0 |
_tCancer cell _gvol. 7 _gno. 6 _gp. 561-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ccr.2005.05.014 _zAvailable from publisher's website |
| 999 |
_c15610400 _d15610400 |
||